https://www.avient.com/products/polymer-additives/processing-enhancement-additives/cesa-plastone-processing-enhancing-additive
Browse and download our literature to learn more about Avient solutions and services.
Product/Service Overview
Product/Service Overview
https://www.avient.com/news/new-non-fluorine-stain-resistant-concentrates-polyester-textiles-avient
To learn more about Cesa stain-resistant concentrates, read our product overview here.
About Avient
By intersecting our broad portfolio of technologies with the product roadmaps of our customers, we help create differentiated and high-performance products that make the world better and more sustainable.
https://www.avient.com/news/polyone-unveils-invisiosm-color-inspiration-2017
Avient Announces Second Quarter 2025 Results...
Avient Announces Quarterly Dividend...
Avient To Hold Second Quarter 2025 Conference Call...
https://www.avient.com/products/engineered-polymer-formulations/conductive-signal-radiation-shielding-formulations/therma-tech-thermally-conductive-formulations
Connect with a Product Expert
Avient's Highly Engineered Materials for the Battery and E-mobility Market
Product/Service Overview
https://www.avient.com/idea/composite-tripod-stands-out-crowd
This unique material is at the heart of every product it makes.
The most recent product in Rolatube’s portfolio is the Revolve™ ultra-compact tripod.
The tripod designers consulted with the advanced composite product experts at Avient, and trialed several formulations of Polystrand™ continuous fiber-reinforced thermoplastic composites.
https://www.avient.com/resource-center/knowledge-base/article/securing-supplies-medical-plastic-solutions?ind%5B0%5D=6598
Companies placing medical devices and packaged pharmaceuticals on the market need their products to comply with healthcare standards, no matter where their products are sold and no matter where they procure their raw materials.
Avient’s Mevopur™ portfolio and risk mitigation concept can help healthcare manufacturers on the journey to increased security of supply for plastics used in their products.
All Mevopur production sites offer change control agreements beyond Chemical Abstracts Service (CAS) number.
https://www.avient.com/resource-center/knowledge-base/article/securing-supplies-medical-plastic-solutions?pname%5B0%5D=17815
Companies placing medical devices and packaged pharmaceuticals on the market need their products to comply with healthcare standards, no matter where their products are sold and no matter where they procure their raw materials.
Avient’s Mevopur™ portfolio and risk mitigation concept can help healthcare manufacturers on the journey to increased security of supply for plastics used in their products.
All Mevopur production sites offer change control agreements beyond Chemical Abstracts Service (CAS) number.
https://www.avient.com/resource-center/knowledge-base/article/reduce-carbon-footprint-medical-plastics
The first priority for manufacturers of healthcare products is to ensure they are safe for users.
Choosing different materials can help reduce the carbon footprint of manufactured products.
Detailed regulatory information is available from your Avient contact.
https://www.avient.com/resource-center/knowledge-base/article/securing-supplies-medical-plastic-solutions
Companies placing medical devices and packaged pharmaceuticals on the market need their products to comply with healthcare standards, no matter where their products are sold and no matter where they procure their raw materials.
Avient’s Mevopur™ portfolio and risk mitigation concept can help healthcare manufacturers on the journey to increased security of supply for plastics used in their products.
All Mevopur production sites offer change control agreements beyond Chemical Abstracts Service (CAS) number.
https://www.avient.com/resource-center/knowledge-base/article/securing-supplies-medical-plastic-solutions?pname%5B0%5D=17814
Companies placing medical devices and packaged pharmaceuticals on the market need their products to comply with healthcare standards, no matter where their products are sold and no matter where they procure their raw materials.
Avient’s Mevopur™ portfolio and risk mitigation concept can help healthcare manufacturers on the journey to increased security of supply for plastics used in their products.
All Mevopur production sites offer change control agreements beyond Chemical Abstracts Service (CAS) number.